Filed: 5/13/2024ACC: 0001910264-24-000003
📋 What this filing means
SR ONE CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $364.09M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$364.09M
Total AUM (reported)
19.29M
Total Shares
Allocation by class
COMMON STOCK$163.21M44.8%
COM$129.38M35.5%
NAMEN AKT$71.50M19.6%
Portfolio Concentration
Top 3$275.72M75.7%
4–10$88.37M24.3%
Top 3 weight
75.7%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 19.29M
Sole
Full voting authority
19.29M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
ARCELLX INC
SOLEShares2.35M
TypeSH
Market value$163.21M
44.83%
Sole
2.35M
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares1.05M
TypeSH
Market value$71.50M
19.64%
Sole
1.05M
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
SOLEShares4.01M
TypeSH
Market value$41.01M
11.26%
Sole
4.01M
Shared
0.00
None
0.00
NKARTA INC
SOLEShares3.33M
TypeSH
Market value$36.03M
9.90%
Sole
3.33M
Shared
0.00
None
0.00
DESIGN THERAPEUTICS INC
SOLEShares6.53M
TypeSH
Market value$26.30M
7.22%
Sole
6.53M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares2.02M
TypeSH
Market value$26.04M
7.15%
Sole
2.02M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARCELLX INCSOLE | COMMON STOCK | 2.35M | SH | $163.21M 44.83% | 2.35M | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 1.05M | SH | $71.50M 19.64% | 1.05M | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCSOLE | COM | 4.01M | SH | $41.01M 11.26% | 4.01M | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 3.33M | SH | $36.03M 9.90% | 3.33M | 0.00 | 0.00 |
DESIGN THERAPEUTICS INCSOLE | COM | 6.53M | SH | $26.30M 7.22% | 6.53M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 2.02M | SH | $26.04M 7.15% | 2.02M | 0.00 | 0.00 |